Additional file 3 of Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig
posted on 2022-06-16, 09:47authored byGremese Elisa, Barbara Tolusso, Luca Petricca, Clara Di Mario, Maria Rita Gigante, Gianfranco Ferraccioli, Stefano Alivernini
Additional file 3: Supplementary Fig. 2. ROC curves for IL-6 (A) and CD4posCD25posFoxP3pos cells rate (B) significantly distinguishing RA patients achieving DAS-defined remission at 6 months of CTLA4-Ig treatment.